Greg Babe is the chief executive of the the Bayer Corporation.

Bayer’s experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency.

The drug maker AstraZeneca, the Bristol-Myers Squibb Company and Bayer reported declines in first-quarter profit on generic competition and costs from cutting jobs.